Pharmaceutical industry market in USA and Japan

aerosol, compound, pipe, pipeline, supply chain, switch, acute stroke, alcohol, alzheimer, antipsychotic, antithrombotic, anxiety, anxiety disorder, atherosclerosis, biotech, bipolar disorder, bipolar disorders, cancer, cardiovascular disease, cell culture, central nervous system, chemotherapy, clinical trials, copd, coronary heart disease, cystic fibrosis, diabetic, dyslipidemia, egg, endometriosis, franchise, heart failure, hypertension, influenza vaccine, influenza vaccines, information technology, infusion, ingredients, microprocessor, osteoarthritis, outsourcing, parkinson, pharmaceutical, pharmaceutical industry, pharmaceuticals, salts, schizophrenia, statins, vaccine, vaccines,

building the next solvay pharmaceuticals werner cautreels general manager of analysts and investors day 3 october 4 2005 sa nv sales 865 922 1049 1167 1349 1548 1769 1863 1832 1745 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 in m eur steady growth industry context price pressure regulatory requirements impact ht business usd mature line product portfolio 5 margins rebit 9 11 12 14 13 6 global organisation 300 meur stepwise efficiency improvements focus key areas specific medical needs marketing excellence performance goals 20 7 revenues